URSOSAN

This brand name is authorized in Australia, Estonia, Croatia, Lithuania, New Zealand, Romania

Active ingredients

The drug URSOSAN contains one active pharmaceutical ingredient (API):

1 Ursodeoxycholic acid UNII 724L30Y2QR - URSODIOL

The ursodeoxycholic acid converts lithogenic bile in non-lithogenic bile and gradually dissolves the cholesterol gallstones. Read about Ursodeoxycholic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A05AA02	Ursodeoxycholic acid	A Alimentary tract and metabolism → A05 Bile and liver therapy → A05A Bile therapy → A05AA Bile acid preparations
Discover more medicines within A05AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8448P
Country: EE	Ravimiamet	Identifier(s): 1016985, 1088489, 1737154, 1737165, 1737176, 1737187, 1737198, 1737200, 1737211, 1737222, 1737233, 1749708, 1771264, 1771275, 1771286, 1771297, 1771309, 1771310
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-394260635
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003877, 1087193, 1087194, 1087195, 1087196, 1087197, 1087198, 1087199, 1087200, 1087391, 1087392, 1087393, 1087394, 1087395, 1087396, 1087397, 1087398, 1087399
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 14939
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W00188001, W00188002